Global Gene Therapy Viral Vector and Plasmid DNA Supply, Demand and Key Producers, 2023-2029
The global Gene Therapy Viral Vector and Plasmid DNA market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Viral vector and plasmid DNA are tools to transfer genetic material into cells. Viral vectors are generally utilized as vectors for gene therapy. There are various types of vectors, such as lentivirus, adenovirus, adeno-associated virus (AAV), and others, which include herpes simplex virus and chimeric viral vectors.
This report studies the global Gene Therapy Viral Vector and Plasmid DNA production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy Viral Vector and Plasmid DNA, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy Viral Vector and Plasmid DNA that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy Viral Vector and Plasmid DNA total production and demand, 2018-2029, (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA total production value, 2018-2029, (USD Million)
Global Gene Therapy Viral Vector and Plasmid DNA production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gene Therapy Viral Vector and Plasmid DNA domestic production, consumption, key domestic manufacturers and share
Global Gene Therapy Viral Vector and Plasmid DNA production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Gene Therapy Viral Vector and Plasmid DNA market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories, Catalent, WuXi AppTec, FUJIFILM, GenScript Biotech and Takara Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy Viral Vector and Plasmid DNA market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Therapy Viral Vector and Plasmid DNA Market, By Region:
1. How big is the global Gene Therapy Viral Vector and Plasmid DNA market?
2. What is the demand of the global Gene Therapy Viral Vector and Plasmid DNA market?
3. What is the year over year growth of the global Gene Therapy Viral Vector and Plasmid DNA market?
4. What is the production and production value of the global Gene Therapy Viral Vector and Plasmid DNA market?
5. Who are the key producers in the global Gene Therapy Viral Vector and Plasmid DNA market?
6. What are the growth factors driving the market demand?
Viral vector and plasmid DNA are tools to transfer genetic material into cells. Viral vectors are generally utilized as vectors for gene therapy. There are various types of vectors, such as lentivirus, adenovirus, adeno-associated virus (AAV), and others, which include herpes simplex virus and chimeric viral vectors.
This report studies the global Gene Therapy Viral Vector and Plasmid DNA production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy Viral Vector and Plasmid DNA, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy Viral Vector and Plasmid DNA that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy Viral Vector and Plasmid DNA total production and demand, 2018-2029, (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA total production value, 2018-2029, (USD Million)
Global Gene Therapy Viral Vector and Plasmid DNA production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gene Therapy Viral Vector and Plasmid DNA domestic production, consumption, key domestic manufacturers and share
Global Gene Therapy Viral Vector and Plasmid DNA production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gene Therapy Viral Vector and Plasmid DNA production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Gene Therapy Viral Vector and Plasmid DNA market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories, Catalent, WuXi AppTec, FUJIFILM, GenScript Biotech and Takara Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy Viral Vector and Plasmid DNA market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Therapy Viral Vector and Plasmid DNA Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Viral Vectors
- Plasmid DNA
- Cell and Gene Therapy
- Vaccine Development
- Research
- Lonza
- Merck KGaA
- Thermo Fisher Scientific
- Charles River Laboratories
- Catalent
- WuXi AppTec
- FUJIFILM
- GenScript Biotech
- Takara Bio
- Oxford Biomedica
- Novartis
- Precision Biosciences
- Bluebird Bio
- Sartorius AG
- Danaher
- SIRON Biotech
- VGXI
- Waisman Biomanufacturing
- Kaneka Eurogentec
- PlasmidFactory
- ATUM
- Addgene
- Cell and Gene Therapy Catapult
- Batavia biosciences
- Altogen Biosystems
1. How big is the global Gene Therapy Viral Vector and Plasmid DNA market?
2. What is the demand of the global Gene Therapy Viral Vector and Plasmid DNA market?
3. What is the year over year growth of the global Gene Therapy Viral Vector and Plasmid DNA market?
4. What is the production and production value of the global Gene Therapy Viral Vector and Plasmid DNA market?
5. Who are the key producers in the global Gene Therapy Viral Vector and Plasmid DNA market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gene Therapy Viral Vector and Plasmid DNA Introduction
1.2 World Gene Therapy Viral Vector and Plasmid DNA Supply & Forecast
1.2.1 World Gene Therapy Viral Vector and Plasmid DNA Production Value (2018 & 2022 & 2029)
1.2.2 World Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.2.3 World Gene Therapy Viral Vector and Plasmid DNA Pricing Trends (2018-2029)
1.3 World Gene Therapy Viral Vector and Plasmid DNA Production by Region (Based on Production Site)
1.3.1 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2018-2029)
1.3.2 World Gene Therapy Viral Vector and Plasmid DNA Production by Region (2018-2029)
1.3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Region (2018-2029)
1.3.4 North America Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.3.5 Europe Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.3.6 China Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.3.7 Japan Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy Viral Vector and Plasmid DNA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Therapy Viral Vector and Plasmid DNA Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Therapy Viral Vector and Plasmid DNA Demand (2018-2029)
2.2 World Gene Therapy Viral Vector and Plasmid DNA Consumption by Region
2.2.1 World Gene Therapy Viral Vector and Plasmid DNA Consumption by Region (2018-2023)
2.2.2 World Gene Therapy Viral Vector and Plasmid DNA Consumption Forecast by Region (2024-2029)
2.3 United States Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.4 China Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.5 Europe Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.6 Japan Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.7 South Korea Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.8 ASEAN Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.9 India Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
3 WORLD GENE THERAPY VIRAL VECTOR AND PLASMID DNA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Manufacturer (2018-2023)
3.2 World Gene Therapy Viral Vector and Plasmid DNA Production by Manufacturer (2018-2023)
3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Manufacturer (2018-2023)
3.4 Gene Therapy Viral Vector and Plasmid DNA Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gene Therapy Viral Vector and Plasmid DNA Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gene Therapy Viral Vector and Plasmid DNA in 2022
3.5.3 Global Concentration Ratios (CR8) for Gene Therapy Viral Vector and Plasmid DNA in 2022
3.6 Gene Therapy Viral Vector and Plasmid DNA Market: Overall Company Footprint Analysis
3.6.1 Gene Therapy Viral Vector and Plasmid DNA Market: Region Footprint
3.6.2 Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Type Footprint
3.6.3 Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Comparison
4.1.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Comparison
4.2.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Comparison
4.3.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value (2018-2023)
4.4.3 United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023)
4.5 China Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers and Market Share
4.5.1 China Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value (2018-2023)
4.5.3 China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023)
4.6 Rest of World Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy Viral Vector and Plasmid DNA Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Vectors
5.2.2 Plasmid DNA
5.3 Market Segment by Type
5.3.1 World Gene Therapy Viral Vector and Plasmid DNA Production by Type (2018-2029)
5.3.2 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type (2018-2029)
5.3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy Viral Vector and Plasmid DNA Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cell and Gene Therapy
6.2.2 Vaccine Development
6.2.3 Research
6.3 Market Segment by Application
6.3.1 World Gene Therapy Viral Vector and Plasmid DNA Production by Application (2018-2029)
6.3.2 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application (2018-2029)
6.3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.1.4 Lonza Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Merck KGaA
7.2.1 Merck KGaA Details
7.2.2 Merck KGaA Major Business
7.2.3 Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.2.4 Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck KGaA Recent Developments/Updates
7.2.6 Merck KGaA Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.3.4 Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Charles River Laboratories
7.4.1 Charles River Laboratories Details
7.4.2 Charles River Laboratories Major Business
7.4.3 Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.4.4 Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Charles River Laboratories Recent Developments/Updates
7.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.5 Catalent
7.5.1 Catalent Details
7.5.2 Catalent Major Business
7.5.3 Catalent Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.5.4 Catalent Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Catalent Recent Developments/Updates
7.5.6 Catalent Competitive Strengths & Weaknesses
7.6 WuXi AppTec
7.6.1 WuXi AppTec Details
7.6.2 WuXi AppTec Major Business
7.6.3 WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.6.4 WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 WuXi AppTec Recent Developments/Updates
7.6.6 WuXi AppTec Competitive Strengths & Weaknesses
7.7 FUJIFILM
7.7.1 FUJIFILM Details
7.7.2 FUJIFILM Major Business
7.7.3 FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.7.4 FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 FUJIFILM Recent Developments/Updates
7.7.6 FUJIFILM Competitive Strengths & Weaknesses
7.8 GenScript Biotech
7.8.1 GenScript Biotech Details
7.8.2 GenScript Biotech Major Business
7.8.3 GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.8.4 GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GenScript Biotech Recent Developments/Updates
7.8.6 GenScript Biotech Competitive Strengths & Weaknesses
7.9 Takara Bio
7.9.1 Takara Bio Details
7.9.2 Takara Bio Major Business
7.9.3 Takara Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.9.4 Takara Bio Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Takara Bio Recent Developments/Updates
7.9.6 Takara Bio Competitive Strengths & Weaknesses
7.10 Oxford Biomedica
7.10.1 Oxford Biomedica Details
7.10.2 Oxford Biomedica Major Business
7.10.3 Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.10.4 Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Oxford Biomedica Recent Developments/Updates
7.10.6 Oxford Biomedica Competitive Strengths & Weaknesses
7.11 Novartis
7.11.1 Novartis Details
7.11.2 Novartis Major Business
7.11.3 Novartis Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.11.4 Novartis Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novartis Recent Developments/Updates
7.11.6 Novartis Competitive Strengths & Weaknesses
7.12 Precision Biosciences
7.12.1 Precision Biosciences Details
7.12.2 Precision Biosciences Major Business
7.12.3 Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.12.4 Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Precision Biosciences Recent Developments/Updates
7.12.6 Precision Biosciences Competitive Strengths & Weaknesses
7.13 Bluebird Bio
7.13.1 Bluebird Bio Details
7.13.2 Bluebird Bio Major Business
7.13.3 Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.13.4 Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Bluebird Bio Recent Developments/Updates
7.13.6 Bluebird Bio Competitive Strengths & Weaknesses
7.14 Sartorius AG
7.14.1 Sartorius AG Details
7.14.2 Sartorius AG Major Business
7.14.3 Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.14.4 Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Sartorius AG Recent Developments/Updates
7.14.6 Sartorius AG Competitive Strengths & Weaknesses
7.15 Danaher
7.15.1 Danaher Details
7.15.2 Danaher Major Business
7.15.3 Danaher Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.15.4 Danaher Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Danaher Recent Developments/Updates
7.15.6 Danaher Competitive Strengths & Weaknesses
7.16 SIRON Biotech
7.16.1 SIRON Biotech Details
7.16.2 SIRON Biotech Major Business
7.16.3 SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.16.4 SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 SIRON Biotech Recent Developments/Updates
7.16.6 SIRON Biotech Competitive Strengths & Weaknesses
7.17 VGXI
7.17.1 VGXI Details
7.17.2 VGXI Major Business
7.17.3 VGXI Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.17.4 VGXI Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 VGXI Recent Developments/Updates
7.17.6 VGXI Competitive Strengths & Weaknesses
7.18 Waisman Biomanufacturing
7.18.1 Waisman Biomanufacturing Details
7.18.2 Waisman Biomanufacturing Major Business
7.18.3 Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.18.4 Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Waisman Biomanufacturing Recent Developments/Updates
7.18.6 Waisman Biomanufacturing Competitive Strengths & Weaknesses
7.19 Kaneka Eurogentec
7.19.1 Kaneka Eurogentec Details
7.19.2 Kaneka Eurogentec Major Business
7.19.3 Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.19.4 Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Kaneka Eurogentec Recent Developments/Updates
7.19.6 Kaneka Eurogentec Competitive Strengths & Weaknesses
7.20 PlasmidFactory
7.20.1 PlasmidFactory Details
7.20.2 PlasmidFactory Major Business
7.20.3 PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.20.4 PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 PlasmidFactory Recent Developments/Updates
7.20.6 PlasmidFactory Competitive Strengths & Weaknesses
7.21 ATUM
7.21.1 ATUM Details
7.21.2 ATUM Major Business
7.21.3 ATUM Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.21.4 ATUM Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 ATUM Recent Developments/Updates
7.21.6 ATUM Competitive Strengths & Weaknesses
7.22 Addgene
7.22.1 Addgene Details
7.22.2 Addgene Major Business
7.22.3 Addgene Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.22.4 Addgene Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Addgene Recent Developments/Updates
7.22.6 Addgene Competitive Strengths & Weaknesses
7.23 Cell and Gene Therapy Catapult
7.23.1 Cell and Gene Therapy Catapult Details
7.23.2 Cell and Gene Therapy Catapult Major Business
7.23.3 Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.23.4 Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Cell and Gene Therapy Catapult Recent Developments/Updates
7.23.6 Cell and Gene Therapy Catapult Competitive Strengths & Weaknesses
7.24 Batavia biosciences
7.24.1 Batavia biosciences Details
7.24.2 Batavia biosciences Major Business
7.24.3 Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.24.4 Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Batavia biosciences Recent Developments/Updates
7.24.6 Batavia biosciences Competitive Strengths & Weaknesses
7.25 Altogen Biosystems
7.25.1 Altogen Biosystems Details
7.25.2 Altogen Biosystems Major Business
7.25.3 Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.25.4 Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Altogen Biosystems Recent Developments/Updates
7.25.6 Altogen Biosystems Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy Viral Vector and Plasmid DNA Industry Chain
8.2 Gene Therapy Viral Vector and Plasmid DNA Upstream Analysis
8.2.1 Gene Therapy Viral Vector and Plasmid DNA Core Raw Materials
8.2.2 Main Manufacturers of Gene Therapy Viral Vector and Plasmid DNA Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gene Therapy Viral Vector and Plasmid DNA Production Mode
8.6 Gene Therapy Viral Vector and Plasmid DNA Procurement Model
8.7 Gene Therapy Viral Vector and Plasmid DNA Industry Sales Model and Sales Channels
8.7.1 Gene Therapy Viral Vector and Plasmid DNA Sales Model
8.7.2 Gene Therapy Viral Vector and Plasmid DNA Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gene Therapy Viral Vector and Plasmid DNA Introduction
1.2 World Gene Therapy Viral Vector and Plasmid DNA Supply & Forecast
1.2.1 World Gene Therapy Viral Vector and Plasmid DNA Production Value (2018 & 2022 & 2029)
1.2.2 World Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.2.3 World Gene Therapy Viral Vector and Plasmid DNA Pricing Trends (2018-2029)
1.3 World Gene Therapy Viral Vector and Plasmid DNA Production by Region (Based on Production Site)
1.3.1 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2018-2029)
1.3.2 World Gene Therapy Viral Vector and Plasmid DNA Production by Region (2018-2029)
1.3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Region (2018-2029)
1.3.4 North America Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.3.5 Europe Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.3.6 China Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.3.7 Japan Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy Viral Vector and Plasmid DNA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Therapy Viral Vector and Plasmid DNA Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Therapy Viral Vector and Plasmid DNA Demand (2018-2029)
2.2 World Gene Therapy Viral Vector and Plasmid DNA Consumption by Region
2.2.1 World Gene Therapy Viral Vector and Plasmid DNA Consumption by Region (2018-2023)
2.2.2 World Gene Therapy Viral Vector and Plasmid DNA Consumption Forecast by Region (2024-2029)
2.3 United States Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.4 China Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.5 Europe Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.6 Japan Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.7 South Korea Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.8 ASEAN Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
2.9 India Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029)
3 WORLD GENE THERAPY VIRAL VECTOR AND PLASMID DNA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Manufacturer (2018-2023)
3.2 World Gene Therapy Viral Vector and Plasmid DNA Production by Manufacturer (2018-2023)
3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Manufacturer (2018-2023)
3.4 Gene Therapy Viral Vector and Plasmid DNA Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gene Therapy Viral Vector and Plasmid DNA Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gene Therapy Viral Vector and Plasmid DNA in 2022
3.5.3 Global Concentration Ratios (CR8) for Gene Therapy Viral Vector and Plasmid DNA in 2022
3.6 Gene Therapy Viral Vector and Plasmid DNA Market: Overall Company Footprint Analysis
3.6.1 Gene Therapy Viral Vector and Plasmid DNA Market: Region Footprint
3.6.2 Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Type Footprint
3.6.3 Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Comparison
4.1.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Comparison
4.2.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Comparison
4.3.1 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value (2018-2023)
4.4.3 United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023)
4.5 China Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers and Market Share
4.5.1 China Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value (2018-2023)
4.5.3 China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023)
4.6 Rest of World Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy Viral Vector and Plasmid DNA Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Vectors
5.2.2 Plasmid DNA
5.3 Market Segment by Type
5.3.1 World Gene Therapy Viral Vector and Plasmid DNA Production by Type (2018-2029)
5.3.2 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type (2018-2029)
5.3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy Viral Vector and Plasmid DNA Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cell and Gene Therapy
6.2.2 Vaccine Development
6.2.3 Research
6.3 Market Segment by Application
6.3.1 World Gene Therapy Viral Vector and Plasmid DNA Production by Application (2018-2029)
6.3.2 World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application (2018-2029)
6.3.3 World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.1.4 Lonza Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Merck KGaA
7.2.1 Merck KGaA Details
7.2.2 Merck KGaA Major Business
7.2.3 Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.2.4 Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck KGaA Recent Developments/Updates
7.2.6 Merck KGaA Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.3.4 Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Charles River Laboratories
7.4.1 Charles River Laboratories Details
7.4.2 Charles River Laboratories Major Business
7.4.3 Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.4.4 Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Charles River Laboratories Recent Developments/Updates
7.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.5 Catalent
7.5.1 Catalent Details
7.5.2 Catalent Major Business
7.5.3 Catalent Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.5.4 Catalent Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Catalent Recent Developments/Updates
7.5.6 Catalent Competitive Strengths & Weaknesses
7.6 WuXi AppTec
7.6.1 WuXi AppTec Details
7.6.2 WuXi AppTec Major Business
7.6.3 WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.6.4 WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 WuXi AppTec Recent Developments/Updates
7.6.6 WuXi AppTec Competitive Strengths & Weaknesses
7.7 FUJIFILM
7.7.1 FUJIFILM Details
7.7.2 FUJIFILM Major Business
7.7.3 FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.7.4 FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 FUJIFILM Recent Developments/Updates
7.7.6 FUJIFILM Competitive Strengths & Weaknesses
7.8 GenScript Biotech
7.8.1 GenScript Biotech Details
7.8.2 GenScript Biotech Major Business
7.8.3 GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.8.4 GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GenScript Biotech Recent Developments/Updates
7.8.6 GenScript Biotech Competitive Strengths & Weaknesses
7.9 Takara Bio
7.9.1 Takara Bio Details
7.9.2 Takara Bio Major Business
7.9.3 Takara Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.9.4 Takara Bio Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Takara Bio Recent Developments/Updates
7.9.6 Takara Bio Competitive Strengths & Weaknesses
7.10 Oxford Biomedica
7.10.1 Oxford Biomedica Details
7.10.2 Oxford Biomedica Major Business
7.10.3 Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.10.4 Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Oxford Biomedica Recent Developments/Updates
7.10.6 Oxford Biomedica Competitive Strengths & Weaknesses
7.11 Novartis
7.11.1 Novartis Details
7.11.2 Novartis Major Business
7.11.3 Novartis Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.11.4 Novartis Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novartis Recent Developments/Updates
7.11.6 Novartis Competitive Strengths & Weaknesses
7.12 Precision Biosciences
7.12.1 Precision Biosciences Details
7.12.2 Precision Biosciences Major Business
7.12.3 Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.12.4 Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Precision Biosciences Recent Developments/Updates
7.12.6 Precision Biosciences Competitive Strengths & Weaknesses
7.13 Bluebird Bio
7.13.1 Bluebird Bio Details
7.13.2 Bluebird Bio Major Business
7.13.3 Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.13.4 Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Bluebird Bio Recent Developments/Updates
7.13.6 Bluebird Bio Competitive Strengths & Weaknesses
7.14 Sartorius AG
7.14.1 Sartorius AG Details
7.14.2 Sartorius AG Major Business
7.14.3 Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.14.4 Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Sartorius AG Recent Developments/Updates
7.14.6 Sartorius AG Competitive Strengths & Weaknesses
7.15 Danaher
7.15.1 Danaher Details
7.15.2 Danaher Major Business
7.15.3 Danaher Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.15.4 Danaher Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Danaher Recent Developments/Updates
7.15.6 Danaher Competitive Strengths & Weaknesses
7.16 SIRON Biotech
7.16.1 SIRON Biotech Details
7.16.2 SIRON Biotech Major Business
7.16.3 SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.16.4 SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 SIRON Biotech Recent Developments/Updates
7.16.6 SIRON Biotech Competitive Strengths & Weaknesses
7.17 VGXI
7.17.1 VGXI Details
7.17.2 VGXI Major Business
7.17.3 VGXI Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.17.4 VGXI Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 VGXI Recent Developments/Updates
7.17.6 VGXI Competitive Strengths & Weaknesses
7.18 Waisman Biomanufacturing
7.18.1 Waisman Biomanufacturing Details
7.18.2 Waisman Biomanufacturing Major Business
7.18.3 Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.18.4 Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Waisman Biomanufacturing Recent Developments/Updates
7.18.6 Waisman Biomanufacturing Competitive Strengths & Weaknesses
7.19 Kaneka Eurogentec
7.19.1 Kaneka Eurogentec Details
7.19.2 Kaneka Eurogentec Major Business
7.19.3 Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.19.4 Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Kaneka Eurogentec Recent Developments/Updates
7.19.6 Kaneka Eurogentec Competitive Strengths & Weaknesses
7.20 PlasmidFactory
7.20.1 PlasmidFactory Details
7.20.2 PlasmidFactory Major Business
7.20.3 PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.20.4 PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 PlasmidFactory Recent Developments/Updates
7.20.6 PlasmidFactory Competitive Strengths & Weaknesses
7.21 ATUM
7.21.1 ATUM Details
7.21.2 ATUM Major Business
7.21.3 ATUM Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.21.4 ATUM Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 ATUM Recent Developments/Updates
7.21.6 ATUM Competitive Strengths & Weaknesses
7.22 Addgene
7.22.1 Addgene Details
7.22.2 Addgene Major Business
7.22.3 Addgene Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.22.4 Addgene Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Addgene Recent Developments/Updates
7.22.6 Addgene Competitive Strengths & Weaknesses
7.23 Cell and Gene Therapy Catapult
7.23.1 Cell and Gene Therapy Catapult Details
7.23.2 Cell and Gene Therapy Catapult Major Business
7.23.3 Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.23.4 Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Cell and Gene Therapy Catapult Recent Developments/Updates
7.23.6 Cell and Gene Therapy Catapult Competitive Strengths & Weaknesses
7.24 Batavia biosciences
7.24.1 Batavia biosciences Details
7.24.2 Batavia biosciences Major Business
7.24.3 Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.24.4 Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Batavia biosciences Recent Developments/Updates
7.24.6 Batavia biosciences Competitive Strengths & Weaknesses
7.25 Altogen Biosystems
7.25.1 Altogen Biosystems Details
7.25.2 Altogen Biosystems Major Business
7.25.3 Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Product and Services
7.25.4 Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Altogen Biosystems Recent Developments/Updates
7.25.6 Altogen Biosystems Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy Viral Vector and Plasmid DNA Industry Chain
8.2 Gene Therapy Viral Vector and Plasmid DNA Upstream Analysis
8.2.1 Gene Therapy Viral Vector and Plasmid DNA Core Raw Materials
8.2.2 Main Manufacturers of Gene Therapy Viral Vector and Plasmid DNA Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Gene Therapy Viral Vector and Plasmid DNA Production Mode
8.6 Gene Therapy Viral Vector and Plasmid DNA Procurement Model
8.7 Gene Therapy Viral Vector and Plasmid DNA Industry Sales Model and Sales Channels
8.7.1 Gene Therapy Viral Vector and Plasmid DNA Sales Model
8.7.2 Gene Therapy Viral Vector and Plasmid DNA Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2018-2023) & (USD Million)
Table 3. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2024-2029) & (USD Million)
Table 4. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Region (2018-2023)
Table 5. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Region (2024-2029)
Table 6. World Gene Therapy Viral Vector and Plasmid DNA Production by Region (2018-2023) & (K Units)
Table 7. World Gene Therapy Viral Vector and Plasmid DNA Production by Region (2024-2029) & (K Units)
Table 8. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Region (2018-2023)
Table 9. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Region (2024-2029)
Table 10. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Gene Therapy Viral Vector and Plasmid DNA Major Market Trends
Table 13. World Gene Therapy Viral Vector and Plasmid DNA Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Gene Therapy Viral Vector and Plasmid DNA Consumption by Region (2018-2023) & (K Units)
Table 15. World Gene Therapy Viral Vector and Plasmid DNA Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Gene Therapy Viral Vector and Plasmid DNA Producers in 2022
Table 18. World Gene Therapy Viral Vector and Plasmid DNA Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Gene Therapy Viral Vector and Plasmid DNA Producers in 2022
Table 20. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Gene Therapy Viral Vector and Plasmid DNA Company Evaluation Quadrant
Table 22. World Gene Therapy Viral Vector and Plasmid DNA Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Gene Therapy Viral Vector and Plasmid DNA Production Site of Key Manufacturer
Table 24. Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Type Footprint
Table 25. Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Application Footprint
Table 26. Gene Therapy Viral Vector and Plasmid DNA Competitive Factors
Table 27. Gene Therapy Viral Vector and Plasmid DNA New Entrant and Capacity Expansion Plans
Table 28. Gene Therapy Viral Vector and Plasmid DNA Mergers & Acquisitions Activity
Table 29. United States VS China Gene Therapy Viral Vector and Plasmid DNA Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Gene Therapy Viral Vector and Plasmid DNA Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Gene Therapy Viral Vector and Plasmid DNA Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share (2018-2023)
Table 37. China Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share (2018-2023)
Table 42. Rest of World Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share (2018-2023)
Table 47. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Gene Therapy Viral Vector and Plasmid DNA Production by Type (2018-2023) & (K Units)
Table 49. World Gene Therapy Viral Vector and Plasmid DNA Production by Type (2024-2029) & (K Units)
Table 50. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type (2018-2023) & (USD Million)
Table 51. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type (2024-2029) & (USD Million)
Table 52. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Gene Therapy Viral Vector and Plasmid DNA Production by Application (2018-2023) & (K Units)
Table 56. World Gene Therapy Viral Vector and Plasmid DNA Production by Application (2024-2029) & (K Units)
Table 57. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application (2018-2023) & (USD Million)
Table 58. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application (2024-2029) & (USD Million)
Table 59. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Lonza Basic Information, Manufacturing Base and Competitors
Table 62. Lonza Major Business
Table 63. Lonza Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 64. Lonza Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Lonza Recent Developments/Updates
Table 66. Lonza Competitive Strengths & Weaknesses
Table 67. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 68. Merck KGaA Major Business
Table 69. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 70. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck KGaA Recent Developments/Updates
Table 72. Merck KGaA Competitive Strengths & Weaknesses
Table 73. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 74. Thermo Fisher Scientific Major Business
Table 75. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 76. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Thermo Fisher Scientific Recent Developments/Updates
Table 78. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 79. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 80. Charles River Laboratories Major Business
Table 81. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 82. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Charles River Laboratories Recent Developments/Updates
Table 84. Charles River Laboratories Competitive Strengths & Weaknesses
Table 85. Catalent Basic Information, Manufacturing Base and Competitors
Table 86. Catalent Major Business
Table 87. Catalent Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 88. Catalent Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Catalent Recent Developments/Updates
Table 90. Catalent Competitive Strengths & Weaknesses
Table 91. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 92. WuXi AppTec Major Business
Table 93. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 94. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. WuXi AppTec Recent Developments/Updates
Table 96. WuXi AppTec Competitive Strengths & Weaknesses
Table 97. FUJIFILM Basic Information, Manufacturing Base and Competitors
Table 98. FUJIFILM Major Business
Table 99. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 100. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. FUJIFILM Recent Developments/Updates
Table 102. FUJIFILM Competitive Strengths & Weaknesses
Table 103. GenScript Biotech Basic Information, Manufacturing Base and Competitors
Table 104. GenScript Biotech Major Business
Table 105. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 106. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GenScript Biotech Recent Developments/Updates
Table 108. GenScript Biotech Competitive Strengths & Weaknesses
Table 109. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 110. Takara Bio Major Business
Table 111. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 112. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Takara Bio Recent Developments/Updates
Table 114. Takara Bio Competitive Strengths & Weaknesses
Table 115. Oxford Biomedica Basic Information, Manufacturing Base and Competitors
Table 116. Oxford Biomedica Major Business
Table 117. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 118. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Oxford Biomedica Recent Developments/Updates
Table 120. Oxford Biomedica Competitive Strengths & Weaknesses
Table 121. Novartis Basic Information, Manufacturing Base and Competitors
Table 122. Novartis Major Business
Table 123. Novartis Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 124. Novartis Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novartis Recent Developments/Updates
Table 126. Novartis Competitive Strengths & Weaknesses
Table 127. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 128. Precision Biosciences Major Business
Table 129. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 130. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Precision Biosciences Recent Developments/Updates
Table 132. Precision Biosciences Competitive Strengths & Weaknesses
Table 133. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 134. Bluebird Bio Major Business
Table 135. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 136. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bluebird Bio Recent Developments/Updates
Table 138. Bluebird Bio Competitive Strengths & Weaknesses
Table 139. Sartorius AG Basic Information, Manufacturing Base and Competitors
Table 140. Sartorius AG Major Business
Table 141. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 142. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Sartorius AG Recent Developments/Updates
Table 144. Sartorius AG Competitive Strengths & Weaknesses
Table 145. Danaher Basic Information, Manufacturing Base and Competitors
Table 146. Danaher Major Business
Table 147. Danaher Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 148. Danaher Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Danaher Recent Developments/Updates
Table 150. Danaher Competitive Strengths & Weaknesses
Table 151. SIRON Biotech Basic Information, Manufacturing Base and Competitors
Table 152. SIRON Biotech Major Business
Table 153. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 154. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. SIRON Biotech Recent Developments/Updates
Table 156. SIRON Biotech Competitive Strengths & Weaknesses
Table 157. VGXI Basic Information, Manufacturing Base and Competitors
Table 158. VGXI Major Business
Table 159. VGXI Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 160. VGXI Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. VGXI Recent Developments/Updates
Table 162. VGXI Competitive Strengths & Weaknesses
Table 163. Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table 164. Waisman Biomanufacturing Major Business
Table 165. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 166. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Waisman Biomanufacturing Recent Developments/Updates
Table 168. Waisman Biomanufacturing Competitive Strengths & Weaknesses
Table 169. Kaneka Eurogentec Basic Information, Manufacturing Base and Competitors
Table 170. Kaneka Eurogentec Major Business
Table 171. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 172. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Kaneka Eurogentec Recent Developments/Updates
Table 174. Kaneka Eurogentec Competitive Strengths & Weaknesses
Table 175. PlasmidFactory Basic Information, Manufacturing Base and Competitors
Table 176. PlasmidFactory Major Business
Table 177. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 178. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. PlasmidFactory Recent Developments/Updates
Table 180. PlasmidFactory Competitive Strengths & Weaknesses
Table 181. ATUM Basic Information, Manufacturing Base and Competitors
Table 182. ATUM Major Business
Table 183. ATUM Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 184. ATUM Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. ATUM Recent Developments/Updates
Table 186. ATUM Competitive Strengths & Weaknesses
Table 187. Addgene Basic Information, Manufacturing Base and Competitors
Table 188. Addgene Major Business
Table 189. Addgene Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 190. Addgene Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Addgene Recent Developments/Updates
Table 192. Addgene Competitive Strengths & Weaknesses
Table 193. Cell and Gene Therapy Catapult Basic Information, Manufacturing Base and Competitors
Table 194. Cell and Gene Therapy Catapult Major Business
Table 195. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 196. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Cell and Gene Therapy Catapult Recent Developments/Updates
Table 198. Cell and Gene Therapy Catapult Competitive Strengths & Weaknesses
Table 199. Batavia biosciences Basic Information, Manufacturing Base and Competitors
Table 200. Batavia biosciences Major Business
Table 201. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 202. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. Batavia biosciences Recent Developments/Updates
Table 204. Altogen Biosystems Basic Information, Manufacturing Base and Competitors
Table 205. Altogen Biosystems Major Business
Table 206. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 207. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 208. Global Key Players of Gene Therapy Viral Vector and Plasmid DNA Upstream (Raw Materials)
Table 209. Gene Therapy Viral Vector and Plasmid DNA Typical Customers
Table 210. Gene Therapy Viral Vector and Plasmid DNA Typical Distributors
Table 1. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2018-2023) & (USD Million)
Table 3. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Region (2024-2029) & (USD Million)
Table 4. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Region (2018-2023)
Table 5. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Region (2024-2029)
Table 6. World Gene Therapy Viral Vector and Plasmid DNA Production by Region (2018-2023) & (K Units)
Table 7. World Gene Therapy Viral Vector and Plasmid DNA Production by Region (2024-2029) & (K Units)
Table 8. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Region (2018-2023)
Table 9. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Region (2024-2029)
Table 10. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Gene Therapy Viral Vector and Plasmid DNA Major Market Trends
Table 13. World Gene Therapy Viral Vector and Plasmid DNA Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Gene Therapy Viral Vector and Plasmid DNA Consumption by Region (2018-2023) & (K Units)
Table 15. World Gene Therapy Viral Vector and Plasmid DNA Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Gene Therapy Viral Vector and Plasmid DNA Producers in 2022
Table 18. World Gene Therapy Viral Vector and Plasmid DNA Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Gene Therapy Viral Vector and Plasmid DNA Producers in 2022
Table 20. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Gene Therapy Viral Vector and Plasmid DNA Company Evaluation Quadrant
Table 22. World Gene Therapy Viral Vector and Plasmid DNA Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Gene Therapy Viral Vector and Plasmid DNA Production Site of Key Manufacturer
Table 24. Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Type Footprint
Table 25. Gene Therapy Viral Vector and Plasmid DNA Market: Company Product Application Footprint
Table 26. Gene Therapy Viral Vector and Plasmid DNA Competitive Factors
Table 27. Gene Therapy Viral Vector and Plasmid DNA New Entrant and Capacity Expansion Plans
Table 28. Gene Therapy Viral Vector and Plasmid DNA Mergers & Acquisitions Activity
Table 29. United States VS China Gene Therapy Viral Vector and Plasmid DNA Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Gene Therapy Viral Vector and Plasmid DNA Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Gene Therapy Viral Vector and Plasmid DNA Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share (2018-2023)
Table 37. China Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share (2018-2023)
Table 42. Rest of World Based Gene Therapy Viral Vector and Plasmid DNA Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share (2018-2023)
Table 47. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Gene Therapy Viral Vector and Plasmid DNA Production by Type (2018-2023) & (K Units)
Table 49. World Gene Therapy Viral Vector and Plasmid DNA Production by Type (2024-2029) & (K Units)
Table 50. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type (2018-2023) & (USD Million)
Table 51. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type (2024-2029) & (USD Million)
Table 52. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Gene Therapy Viral Vector and Plasmid DNA Production by Application (2018-2023) & (K Units)
Table 56. World Gene Therapy Viral Vector and Plasmid DNA Production by Application (2024-2029) & (K Units)
Table 57. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application (2018-2023) & (USD Million)
Table 58. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application (2024-2029) & (USD Million)
Table 59. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Lonza Basic Information, Manufacturing Base and Competitors
Table 62. Lonza Major Business
Table 63. Lonza Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 64. Lonza Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Lonza Recent Developments/Updates
Table 66. Lonza Competitive Strengths & Weaknesses
Table 67. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 68. Merck KGaA Major Business
Table 69. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 70. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck KGaA Recent Developments/Updates
Table 72. Merck KGaA Competitive Strengths & Weaknesses
Table 73. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 74. Thermo Fisher Scientific Major Business
Table 75. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 76. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Thermo Fisher Scientific Recent Developments/Updates
Table 78. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 79. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 80. Charles River Laboratories Major Business
Table 81. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 82. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Charles River Laboratories Recent Developments/Updates
Table 84. Charles River Laboratories Competitive Strengths & Weaknesses
Table 85. Catalent Basic Information, Manufacturing Base and Competitors
Table 86. Catalent Major Business
Table 87. Catalent Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 88. Catalent Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Catalent Recent Developments/Updates
Table 90. Catalent Competitive Strengths & Weaknesses
Table 91. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 92. WuXi AppTec Major Business
Table 93. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 94. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. WuXi AppTec Recent Developments/Updates
Table 96. WuXi AppTec Competitive Strengths & Weaknesses
Table 97. FUJIFILM Basic Information, Manufacturing Base and Competitors
Table 98. FUJIFILM Major Business
Table 99. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 100. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. FUJIFILM Recent Developments/Updates
Table 102. FUJIFILM Competitive Strengths & Weaknesses
Table 103. GenScript Biotech Basic Information, Manufacturing Base and Competitors
Table 104. GenScript Biotech Major Business
Table 105. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 106. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GenScript Biotech Recent Developments/Updates
Table 108. GenScript Biotech Competitive Strengths & Weaknesses
Table 109. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 110. Takara Bio Major Business
Table 111. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 112. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Takara Bio Recent Developments/Updates
Table 114. Takara Bio Competitive Strengths & Weaknesses
Table 115. Oxford Biomedica Basic Information, Manufacturing Base and Competitors
Table 116. Oxford Biomedica Major Business
Table 117. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 118. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Oxford Biomedica Recent Developments/Updates
Table 120. Oxford Biomedica Competitive Strengths & Weaknesses
Table 121. Novartis Basic Information, Manufacturing Base and Competitors
Table 122. Novartis Major Business
Table 123. Novartis Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 124. Novartis Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novartis Recent Developments/Updates
Table 126. Novartis Competitive Strengths & Weaknesses
Table 127. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 128. Precision Biosciences Major Business
Table 129. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 130. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Precision Biosciences Recent Developments/Updates
Table 132. Precision Biosciences Competitive Strengths & Weaknesses
Table 133. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 134. Bluebird Bio Major Business
Table 135. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 136. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bluebird Bio Recent Developments/Updates
Table 138. Bluebird Bio Competitive Strengths & Weaknesses
Table 139. Sartorius AG Basic Information, Manufacturing Base and Competitors
Table 140. Sartorius AG Major Business
Table 141. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 142. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Sartorius AG Recent Developments/Updates
Table 144. Sartorius AG Competitive Strengths & Weaknesses
Table 145. Danaher Basic Information, Manufacturing Base and Competitors
Table 146. Danaher Major Business
Table 147. Danaher Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 148. Danaher Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Danaher Recent Developments/Updates
Table 150. Danaher Competitive Strengths & Weaknesses
Table 151. SIRON Biotech Basic Information, Manufacturing Base and Competitors
Table 152. SIRON Biotech Major Business
Table 153. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 154. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. SIRON Biotech Recent Developments/Updates
Table 156. SIRON Biotech Competitive Strengths & Weaknesses
Table 157. VGXI Basic Information, Manufacturing Base and Competitors
Table 158. VGXI Major Business
Table 159. VGXI Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 160. VGXI Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. VGXI Recent Developments/Updates
Table 162. VGXI Competitive Strengths & Weaknesses
Table 163. Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table 164. Waisman Biomanufacturing Major Business
Table 165. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 166. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Waisman Biomanufacturing Recent Developments/Updates
Table 168. Waisman Biomanufacturing Competitive Strengths & Weaknesses
Table 169. Kaneka Eurogentec Basic Information, Manufacturing Base and Competitors
Table 170. Kaneka Eurogentec Major Business
Table 171. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 172. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Kaneka Eurogentec Recent Developments/Updates
Table 174. Kaneka Eurogentec Competitive Strengths & Weaknesses
Table 175. PlasmidFactory Basic Information, Manufacturing Base and Competitors
Table 176. PlasmidFactory Major Business
Table 177. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 178. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. PlasmidFactory Recent Developments/Updates
Table 180. PlasmidFactory Competitive Strengths & Weaknesses
Table 181. ATUM Basic Information, Manufacturing Base and Competitors
Table 182. ATUM Major Business
Table 183. ATUM Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 184. ATUM Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. ATUM Recent Developments/Updates
Table 186. ATUM Competitive Strengths & Weaknesses
Table 187. Addgene Basic Information, Manufacturing Base and Competitors
Table 188. Addgene Major Business
Table 189. Addgene Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 190. Addgene Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Addgene Recent Developments/Updates
Table 192. Addgene Competitive Strengths & Weaknesses
Table 193. Cell and Gene Therapy Catapult Basic Information, Manufacturing Base and Competitors
Table 194. Cell and Gene Therapy Catapult Major Business
Table 195. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 196. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Cell and Gene Therapy Catapult Recent Developments/Updates
Table 198. Cell and Gene Therapy Catapult Competitive Strengths & Weaknesses
Table 199. Batavia biosciences Basic Information, Manufacturing Base and Competitors
Table 200. Batavia biosciences Major Business
Table 201. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 202. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. Batavia biosciences Recent Developments/Updates
Table 204. Altogen Biosystems Basic Information, Manufacturing Base and Competitors
Table 205. Altogen Biosystems Major Business
Table 206. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Product and Services
Table 207. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 208. Global Key Players of Gene Therapy Viral Vector and Plasmid DNA Upstream (Raw Materials)
Table 209. Gene Therapy Viral Vector and Plasmid DNA Typical Customers
Table 210. Gene Therapy Viral Vector and Plasmid DNA Typical Distributors
LIST OF FIGURES
Figure 1. Gene Therapy Viral Vector and Plasmid DNA Picture
Figure 2. World Gene Therapy Viral Vector and Plasmid DNA Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Therapy Viral Vector and Plasmid DNA Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 5. World Gene Therapy Viral Vector and Plasmid DNA Average Price (2018-2029) & (US$/Unit)
Figure 6. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Region (2018-2029)
Figure 7. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Region (2018-2029)
Figure 8. North America Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 9. Europe Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 10. China Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 11. Japan Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 12. Gene Therapy Viral Vector and Plasmid DNA Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 15. World Gene Therapy Viral Vector and Plasmid DNA Consumption Market Share by Region (2018-2029)
Figure 16. United States Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 17. China Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 18. Europe Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 19. Japan Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 20. South Korea Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 22. India Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Gene Therapy Viral Vector and Plasmid DNA by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gene Therapy Viral Vector and Plasmid DNA Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gene Therapy Viral Vector and Plasmid DNA Markets in 2022
Figure 26. United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share 2022
Figure 30. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share 2022
Figure 32. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Type in 2022
Figure 34. Viral Vectors
Figure 35. Plasmid DNA
Figure 36. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Type (2018-2029)
Figure 37. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Type (2018-2029)
Figure 38. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Application in 2022
Figure 41. Cell and Gene Therapy
Figure 42. Vaccine Development
Figure 43. Research
Figure 44. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Application (2018-2029)
Figure 45. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Application (2018-2029)
Figure 46. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Gene Therapy Viral Vector and Plasmid DNA Industry Chain
Figure 48. Gene Therapy Viral Vector and Plasmid DNA Procurement Model
Figure 49. Gene Therapy Viral Vector and Plasmid DNA Sales Model
Figure 50. Gene Therapy Viral Vector and Plasmid DNA Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Gene Therapy Viral Vector and Plasmid DNA Picture
Figure 2. World Gene Therapy Viral Vector and Plasmid DNA Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Therapy Viral Vector and Plasmid DNA Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 5. World Gene Therapy Viral Vector and Plasmid DNA Average Price (2018-2029) & (US$/Unit)
Figure 6. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Region (2018-2029)
Figure 7. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Region (2018-2029)
Figure 8. North America Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 9. Europe Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 10. China Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 11. Japan Gene Therapy Viral Vector and Plasmid DNA Production (2018-2029) & (K Units)
Figure 12. Gene Therapy Viral Vector and Plasmid DNA Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 15. World Gene Therapy Viral Vector and Plasmid DNA Consumption Market Share by Region (2018-2029)
Figure 16. United States Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 17. China Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 18. Europe Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 19. Japan Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 20. South Korea Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 22. India Gene Therapy Viral Vector and Plasmid DNA Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Gene Therapy Viral Vector and Plasmid DNA by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Gene Therapy Viral Vector and Plasmid DNA Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Gene Therapy Viral Vector and Plasmid DNA Markets in 2022
Figure 26. United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Gene Therapy Viral Vector and Plasmid DNA Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Therapy Viral Vector and Plasmid DNA Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share 2022
Figure 30. China Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Gene Therapy Viral Vector and Plasmid DNA Production Market Share 2022
Figure 32. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Type in 2022
Figure 34. Viral Vectors
Figure 35. Plasmid DNA
Figure 36. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Type (2018-2029)
Figure 37. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Type (2018-2029)
Figure 38. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Gene Therapy Viral Vector and Plasmid DNA Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Application in 2022
Figure 41. Cell and Gene Therapy
Figure 42. Vaccine Development
Figure 43. Research
Figure 44. World Gene Therapy Viral Vector and Plasmid DNA Production Market Share by Application (2018-2029)
Figure 45. World Gene Therapy Viral Vector and Plasmid DNA Production Value Market Share by Application (2018-2029)
Figure 46. World Gene Therapy Viral Vector and Plasmid DNA Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Gene Therapy Viral Vector and Plasmid DNA Industry Chain
Figure 48. Gene Therapy Viral Vector and Plasmid DNA Procurement Model
Figure 49. Gene Therapy Viral Vector and Plasmid DNA Sales Model
Figure 50. Gene Therapy Viral Vector and Plasmid DNA Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
